Sphera Funds Management’s Wave Life Sciences WVE Stock Holding History

Sphera Funds Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.71M	Buy	638,272 +90,000	+16%	+$597K	0.48%	71
2026 Q1	$3.97M	Buy	548,272 +140,106	+34%	+$1.83M	0.63%	59
2025 Q4	$6.94M	Buy	408,166 +358,166	+716%	+$3.64M	1.34%	24
2025 Q3	$366K	Buy	+50,000	New	+$405K	0.08%	109
2021 Q1	–	Sell	-414,959	Closed	-$3.27M	–	203
2020 Q4	$3.27M	Sell	414,959 -516,241	-55%	-$4.33M	0.29%	78
2020 Q3	$7.91M	Buy	931,200 +638,200	+218%	+$7M	0.78%	37
2020 Q2	$3.05M	Buy	+293,000	New	+$2.76M	0.29%	64
2019 Q3	–	Sell	-307,967	Closed	-$8.04M	–	104
2019 Q2	$8.04M	Buy	+307,967	New	+$8.64M	1.1%	25

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Sphera Funds Management's WVE Position: Q2 2026 in Review

Sphera Funds Management increased its Wave Life Sciences (WVE) stake by 16% in Q2 2026, buying an estimated $597K and bringing the position to 638,272 shares worth $3.71M. The position accounts for 0.48% of the portfolio, ranked #71.

Sphera Funds Management first reported a position in WVE in Q2 2019 and has held it in 8 quarters since. The position peaked at $8.04M in Q2 2019. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Sphera Funds Management held 638,272 shares of Wave Life Sciences worth $3.71M as of Q2 2026.
Sphera Funds Management bought 90,000 Wave Life Sciences shares in Q2 2026, an estimated $597K.
Wave Life Sciences made up 0.48% of Sphera Funds Management's portfolio in Q2 2026, its #71 holding.
Sphera Funds Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 8 quarters since.
Sphera Funds Management's Wave Life Sciences position peaked at $8.04M in Q2 2019.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.